Gregg W Stone

Summary

Affiliation: Cardiovascular Research Foundation
Country: USA

Publications

  1. doi request reprint The next 10 years in interventional cardiology. Interview by Louise Rishton
    Gregg W Stone
    Center for Interventional Vascular Therapy, Columbia University Medical Center, NY, USA
    Expert Rev Cardiovasc Ther 11:537-40. 2013
  2. ncbi request reprint Long-term care after percutaneous coronary intervention: focus on the role of antiplatelet therapy
    Gregg W Stone
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY 10022, USA
    Mayo Clin Proc 81:641-52. 2006
  3. ncbi request reprint Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry
    Gregg W Stone
    Cardiovascular Research Foundation and Lenox Hill Hospital, 55 East 59th Street, 6th Floor, New York, NY 10022, USA
    J Am Coll Cardiol 41:1940-5. 2003
  4. ncbi request reprint One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial
    Gregg W Stone
    The Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, 55 E 59th St, 6th Floor, New York, NY 10022, USA
    Circulation 109:1942-7. 2004
  5. ncbi request reprint Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts
    Gregg W Stone
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, 55 E 59th St, 6th Floor, New York, NY 10022, USA
    Circulation 108:548-53. 2003
  6. ncbi request reprint Usefulness of beta radiation for de novo and in-stent restenotic lesions in saphenous vein grafts
    Gregg W Stone
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 92:312-4. 2003
  7. ncbi request reprint Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial
    Gregg W Stone
    Department of Cardiology, Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, NY 10022, USA
    JAMA 290:2284-91. 2003
  8. ncbi request reprint Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries
    Gregg W Stone
    Cardiovascular Research Foundation and Lenox Hill Hospital, New York, New York 10022, USA
    J Am Coll Cardiol 42:2007-13. 2003
  9. ncbi request reprint A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease
    Gregg W Stone
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York 10022, USA
    N Engl J Med 350:221-31. 2004
  10. ncbi request reprint Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale
    Gregg W Stone
    Columbia University Medical Center, Cardiovascular Research Foundation, New York, NY 10022, USA
    Am Heart J 148:764-75. 2004

Collaborators

Detail Information

Publications125 found, 100 shown here

  1. doi request reprint The next 10 years in interventional cardiology. Interview by Louise Rishton
    Gregg W Stone
    Center for Interventional Vascular Therapy, Columbia University Medical Center, NY, USA
    Expert Rev Cardiovasc Ther 11:537-40. 2013
    ..Stone's medical practice is devoted to interventional cardiology procedures at Columbia University Medical Center...
  2. ncbi request reprint Long-term care after percutaneous coronary intervention: focus on the role of antiplatelet therapy
    Gregg W Stone
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY 10022, USA
    Mayo Clin Proc 81:641-52. 2006
    ..In this context, dual antiplatelet therapy (aspirin plus clopidogrel) is recommended for at least 12 months after PCI for prophylaxis of future atherothrombotic events...
  3. ncbi request reprint Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry
    Gregg W Stone
    Cardiovascular Research Foundation and Lenox Hill Hospital, 55 East 59th Street, 6th Floor, New York, NY 10022, USA
    J Am Coll Cardiol 41:1940-5. 2003
    ..We sought to examine contemporary utilization patterns and clinical outcomes in patients with acute myocardial infarction (AMI) requiring intra-aortic balloon pump (IABP) counterpulsation...
  4. ncbi request reprint One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial
    Gregg W Stone
    The Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, 55 E 59th St, 6th Floor, New York, NY 10022, USA
    Circulation 109:1942-7. 2004
    ..The safety and efficacy of the slow-release, polymer-based, paclitaxel-eluting stent after implantation in a broad cross section of de novo coronary lesions at 1 year are unknown...
  5. ncbi request reprint Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts
    Gregg W Stone
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, 55 E 59th St, 6th Floor, New York, NY 10022, USA
    Circulation 108:548-53. 2003
    ..Whether filter-based catheters, which offer the inherent advantages of maintained perfusion and ease of use, are as effective for this purpose has not been established...
  6. ncbi request reprint Usefulness of beta radiation for de novo and in-stent restenotic lesions in saphenous vein grafts
    Gregg W Stone
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 92:312-4. 2003
    ..Clinical and angiographic recurrence rates at 12 months were low, especially in de novo lesions...
  7. ncbi request reprint Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial
    Gregg W Stone
    Department of Cardiology, Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, NY 10022, USA
    JAMA 290:2284-91. 2003
    ....
  8. ncbi request reprint Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries
    Gregg W Stone
    Cardiovascular Research Foundation and Lenox Hill Hospital, New York, New York 10022, USA
    J Am Coll Cardiol 42:2007-13. 2003
    ....
  9. ncbi request reprint A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease
    Gregg W Stone
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York 10022, USA
    N Engl J Med 350:221-31. 2004
    ..Restenosis after coronary stenting necessitates repeated percutaneous or surgical revascularization procedures. The delivery of paclitaxel to the site of vascular injury may reduce the incidence of neointimal hyperplasia and restenosis...
  10. ncbi request reprint Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale
    Gregg W Stone
    Columbia University Medical Center, Cardiovascular Research Foundation, New York, NY 10022, USA
    Am Heart J 148:764-75. 2004
    ..Pilot trials suggest that the thrombin-specific anticoagulant bivalirudin may improve clinical outcomes in ACS...
  11. ncbi request reprint Safety and efficacy of a novel device for treatment of thrombotic and atherosclerotic lesions in native coronary arteries and saphenous vein grafts: results from the multicenter X-Sizer for treatment of thrombus and atherosclerosis in coronary application
    Gregg W Stone
    The Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10021, USA
    Catheter Cardiovasc Interv 58:419-27. 2003
    ..0%, and any MACE in 6.0%. We conclude that the use of the X-Sizer prior to percutaneous intervention is safe in high-risk vein grafts and thrombotic lesions and results in a low rate of adverse events compared to historical controls...
  12. ncbi request reprint Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial
    Gregg W Stone
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10022, USA
    Circulation 105:2347-54. 2002
    ..Also unknown is whether the acuity of the presenting clinical syndrome, which may affect the degree of platelet inhibition required or achieved, influences the response to different antiplatelet agents...
  13. ncbi request reprint Impact of normalized myocardial perfusion after successful angioplasty in acute myocardial infarction
    Gregg W Stone
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Am Coll Cardiol 39:591-7. 2002
    ..We sought to evaluate and validate the ability of the angiographic myocardial blush grade to risk stratify patients after successful angioplasty in acute myocardial infarction (AMI)...
  14. ncbi request reprint Distal filter protection during saphenous vein graft stenting: technical and clinical correlates of efficacy
    Gregg W Stone
    The Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, NY 10022, USA
    J Am Coll Cardiol 40:1882-8. 2002
    ..The aim of this study was to evaluate the clinical, angiographic, and technical factors related to successful stenting of diseased saphenous vein grafts (SVGs) using a novel filter-based distal protection device...
  15. ncbi request reprint Primary angioplasty versus "earlier" thrombolysis--time for a wake-up call
    Gregg W Stone
    Lenox Hill Heart and Vascular Institute, Cardiovascular Research Foundation, New York City, NY 10022, USA
    Lancet 360:814-6. 2002
  16. ncbi request reprint Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction
    Gregg W Stone
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, NY 10022, USA
    N Engl J Med 346:957-66. 2002
    ..When used in combination with PTCA, coronary stenting and platelet glycoprotein IIb/IIIa inhibitors may further improve outcomes...
  17. ncbi request reprint A prospective, multicenter, randomized trial of percutaneous transmyocardial laser revascularization in patients with nonrecanalizable chronic total occlusions
    Gregg W Stone
    Cardiovascular Research Foundation, New York, New York 10021, USA
    J Am Coll Cardiol 39:1581-7. 2002
    ..We sought to evaluate the safety and efficacy of percutaneous transmyocardial revascularization (PTMR) in patients with refractory angina caused by one or more chronic total occlusions (CTOs) of a native coronary artery...
  18. doi request reprint Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial
    Eugenia Nikolsky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
    J Am Coll Cardiol 54:1293-302. 2009
    ..We assessed the incidence, predictors, and outcomes of gastrointestinal bleeding (GIB) in patients with acute coronary syndromes (ACS)...
  19. doi request reprint Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY)
    Roxana Mehran
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York 10032, USA
    JACC Cardiovasc Interv 2:748-57. 2009
    ....
  20. doi request reprint Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial)
    Kenichi Tsujita
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 105:1385-94. 2010
    ..Paradoxically, in this post hoc analysis, the reductions in major bleeding and mortality in ST elevation myocardial infarction afforded by bivalirudin occurred primarily in patients without baseline anemia...
  21. doi request reprint Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial)
    Alexandra J Lansky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 103:1196-203. 2009
    ..In women, bivalirudin monotherapy compared with a GPI-based strategy resulted in significantly decreased bleeding but similar rates of 1-year composite ischemia and mortality...
  22. ncbi request reprint A risk score to predict bleeding in patients with acute coronary syndromes
    Roxana Mehran
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York 10032, USA
    J Am Coll Cardiol 55:2556-66. 2010
    ..The aim of this study was to develop a practical risk score to predict the risk and implications of major bleeding in acute coronary syndromes (ACS)...
  23. doi request reprint Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial In
    Adam J Saltzman
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    JACC Cardiovasc Interv 4:1011-9. 2011
    ..This study sought to investigate the impact of chronic kidney disease (CKD) in patients undergoing percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) with different antithrombotic strategies...
  24. doi request reprint Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial)
    Kenji Goto
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 108:1387-94. 2011
    ..Bivalirudin monotherapy compared to UFH plus a GPI decreased major bleeding regardless of smoking status but may have different effects on individual components of ischemic events...
  25. doi request reprint Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials
    Hiroshi Doi
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
    JACC Cardiovasc Interv 2:1269-75. 2009
    ..We investigated the predictive value of the intravascular ultrasound (IVUS) measured post-intervention minimum stent area (MSA) on 9-month follow-up paclitaxel-eluting stent (PES) patency compared with bare-metal stents (BMS)...
  26. doi request reprint The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale
    Roxana Mehran
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10032, USA
    Am Heart J 156:44-56. 2008
    ..Newer pharmacologic agents and drug-eluting stents may address both of these issues...
  27. doi request reprint Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction
    George D Dangas
    Cardiovascular Institute, Mount Sinai Medical Center, One Gustave L Levy Place, New York, NY 10029, USA
    Circulation 123:1745-56. 2011
    ..Concerns persist regarding the risk of stent thrombosis in the setting of primary percutaneous coronary intervention for ST-segment elevation myocardial infarction...
  28. ncbi request reprint Impact of smoking status on outcomes of primary coronary intervention for acute myocardial infarction--the smoker's paradox revisited
    Giora Weisz
    Cardiovascular Research Foundation and Center for Interventional Therapy, New York, NY, USA
    Am Heart J 150:358-64. 2005
    ..We sought to determine the relationship between cigarette smoking and outcomes after mechanical reperfusion therapy in acute myocardial infarction (AMI)...
  29. doi request reprint Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial
    Roxana Mehran
    Columbia University Medical Center New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY, USA
    Lancet 374:1149-59. 2009
    ..Here, we assess whether these initial benefits were maintained at 1 year of follow-up...
  30. ncbi request reprint Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial
    Eugenia Nikolsky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10032, USA
    JACC Cardiovasc Interv 2:624-32. 2009
    ..We sought to determine the relationship between red blood cell (RBC) transfusion and clinical outcomes in patients undergoing primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI)...
  31. doi request reprint Impact of bleeding on mortality after percutaneous coronary intervention results from a patient-level pooled analysis of the REPLACE-2 (randomized evaluation of PCI linking angiomax to reduced clinical events), ACUITY (acute catheterization and urgent int
    Roxana Mehran
    Department of Cardiology, Mount Sinai Medical Center, New York, New York, USA
    JACC Cardiovasc Interv 4:654-64. 2011
    ..This study sought to develop a risk score predictive of bleeding in patients undergoing percutaneous coronary intervention (PCI) and to investigate the impact of bleeding on subsequent mortality...
  32. doi request reprint Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent
    Bimmer E Claessen
    New York Presbyterian Hospital, Columbia University, New York, NY, USA
    JACC Cardiovasc Interv 4:1209-15. 2011
    ..The aim of this study was to investigate the impact of reference vessel diameter (RVD) and lesion length (LL) on the relative safety and efficacy of everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES)...
  33. doi request reprint Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial
    Gregg W Stone
    New York Presbyterian Hospital, Columbia University Medical Center, New York, NY 10022, USA
    Lancet 377:2193-204. 2011
    ..Primary results of the HORIZONS-AMI trial have been previously reported. In this final report, we aimed to assess 3-year outcomes...
  34. ncbi request reprint Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era
    Tereza Pucelikova
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
    Am J Cardiol 101:63-8. 2008
    ..025). In conclusion, our data show that patients with SVG lesions remain a high-risk subgroup with worse outcomes after percutaneous coronary intervention compared with native vessel disease even in the era of drug-eluting stents...
  35. ncbi request reprint Impact of baseline platelet count in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction (from the CADILLAC trial)
    Eugenia Nikolsky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 99:1055-61. 2007
    ..03, 95% CI 1.00 to 1.06, p = 0.055) at 1 year. In conclusion, a higher baseline platelet count in patients with AMI is a powerful independent predictor of death and reinfarction within the first year after primary PCI...
  36. ncbi request reprint Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention
    Eugenia Nikolsky
    Cardiovascular Research Foundation, and Lenox Hill Heart and Vascular Institute, New York, New York, USA
    Am J Cardiol 94:300-5. 2004
    ..Contrast-induced nephropathy was among the independent predictors of a 1-year mortality rate (OR 2.75, p <0.001)...
  37. doi request reprint Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction
    Gregg W Stone
    Columbia University Medical Center and New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY 10022, USA
    N Engl J Med 360:1946-59. 2009
    ....
  38. doi request reprint Role of clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: results from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial
    George Dangas
    Columbia University Medical Center, New York, New York Cardiovascular Research Foundation, New York, New York 10022, USA
    J Am Coll Cardiol 54:1438-46. 2009
    ....
  39. ncbi request reprint Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial
    Gregg W Stone
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
    Lancet 369:907-19. 2007
    ..The aim of this study was to assess anticoagulation with the direct thrombin inhibitor bivalirudin during percutaneous coronary intervention in individuals with moderate and high-risk acute coronary syndromes...
  40. ncbi request reprint Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial
    Eugenia Nikolsky
    Cardiovascular Research Foundation, New York, New York 10022, USA
    J Am Coll Cardiol 44:547-53. 2004
    ..We sought to investigate the impact of anemia in patients with acute myocardial infarction (AMI) undergoing primary percutaneous coronary intervention (PCI)...
  41. doi request reprint Intravascular ultrasound comparison of the retrograde versus antegrade approach to percutaneous intervention for chronic total coronary occlusions
    Kenichi Tsujita
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York 10022, USA
    JACC Cardiovasc Interv 2:846-54. 2009
    ..We sought to evaluate the results of the antegrade versus retrograde chronic total occlusion (CTO) technique with intravascular ultrasound (IVUS) imaging...
  42. doi request reprint Comparison between ticlopidine and clopidogrel in patients undergoing primary stenting in acute myocardial infarction: results from the CADILLAC trial
    Alexandra J Lansky
    Columbia University Medical Center, Department of Cardiology, Cardiovascular Research Foundation, New York, New York 10022, USA
    Catheter Cardiovasc Interv 72:917-24. 2008
    ..The aim of this article is to examine whether clopidogrel and ticlopidine treatments produce similar clinical outcomes for patients receiving primary stenting for acute myocardial infarction (AMI)...
  43. doi request reprint Non-fibroatheroma lesion phenotype and long-term clinical outcomes: a substudy analysis from the PROSPECT study
    Tomotaka Dohi
    Columbia University Medical Center, New York, New York, USA
    JACC Cardiovasc Imaging 6:908-16. 2013
    ..The purpose of this study was to determine the clinical impact of non-fibroatheroma lesion phenotype in patients presenting with an acute coronary syndrome (ACS)...
  44. doi request reprint Plaque shift and distal embolism in patients with acute myocardial infarction: a volumetric intravascular ultrasound analysis from the HORIZONS-AMI trial
    Xiaofan Wu
    Columbia University Medical Center, New York 10022, USA
    Catheter Cardiovasc Interv 82:203-9. 2013
    ..Vessel expansion and axial plaque redistribution or distal plaque embolization contribute to the increase in lumen dimensions after stent implantation...
  45. doi request reprint Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent)
    Stephen G Ellis
    Cleveland Clinic, Department of Cardiology, Cleveland, Ohio 44195, USA
    JACC Cardiovasc Interv 2:1248-59. 2009
    ....
  46. ncbi request reprint Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound
    Masashi Kimura
    The Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 98:436-42. 2006
    ..Although most ISAs after SES implantation do not resolve completely, the incidence of restenosis or thrombosis is not affected...
  47. doi request reprint Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial Program
    Gregg W Stone
    Department of Cardiology, Columbia University, Medical Center New York Presbyterian Hospital, New York, New York 10022, USA
    JACC Cardiovasc Interv 4:530-42. 2011
    ..These studies sought to evaluate the clinical outcomes of the slow-release Taxus paclitaxel-eluting stent (PES) versus an otherwise identical bare-metal stent (BMS)...
  48. ncbi request reprint Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation
    Hideo Takebayashi
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, NY 10022, USA
    Circulation 110:3430-4. 2004
    ..Little is known about causes of intimal hyperplasia (IH) after sirolimus-eluting stent (SES) implantation...
  49. ncbi request reprint Outcomes of patients with coronary artery perforation complicating percutaneous coronary intervention and correlations with the type of adjunctive antithrombotic therapy: pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials
    Jacob A Doll
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, USA
    J Interv Cardiol 22:453-9. 2009
    ..The lack of a specific counteragent to bivalirudin may complicate the management of patients with coronary artery (CA) perforation during percutaneous coronary intervention (PCI)...
  50. doi request reprint Impact of thienopyridine administration prior to primary stenting in acute myocardial infarction
    LeRoy E Rabbani
    Columbia University Medical Center, Cardiovascular Research Foundation, New York, New York 10032, USA
    J Interv Cardiol 22:378-84. 2009
    ....
  51. ncbi request reprint An evaluation of fluoroscopy time and correlation with outcomes after percutaneous coronary intervention
    Eugenia Nikolsky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York City, NY 10022, USA
    J Invasive Cardiol 19:208-13. 2007
    ..We evaluated short-term prognosis and resource utilization of consecutive patients treated with percutaneous coronary intervention (PCI) as a function of fluoroscopy time...
  52. ncbi request reprint Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial
    Gregg W Stone
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
    JAMA 298:2497-506. 2007
    ....
  53. ncbi request reprint Creatine kinase-MB enzyme elevation and long-term clinical events after successful coronary stenting in lesions with ruptured plaque
    Kenichi Fujii
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York, USA
    Am J Cardiol 95:355-9. 2005
    ..Plaque rupture morphology is associated with higher periprocedural CK-MB release and worse 1-year clinical outcome in patients treated with coronary stenting...
  54. doi request reprint Clinical outcomes following stent thrombosis occurring in-hospital versus out-of-hospital: results from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) trial
    George D Dangas
    Department of Cardiology, Mount Sinai Medical Center, New York, New York 10029, USA
    J Am Coll Cardiol 59:1752-9. 2012
    ....
  55. ncbi request reprint Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions
    Eugenia Nikolsky
    Cardiovascular Research Foundation, New York, NY 10022, USA
    Am J Cardiol 93:1536-9. 2004
    ..These 2 conditions are associated with adverse in-hospital and 1-year outcomes and independently predict early and 1-year mortality...
  56. doi request reprint Bivalirudin during primary PCI in acute myocardial infarction
    Gregg W Stone
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
    N Engl J Med 358:2218-30. 2008
    ..The safety and efficacy of bivalirudin in high-risk patients are unknown...
  57. doi request reprint Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial
    Alexandra J Lansky
    Columbia University Medical Center, New York, NY 10022, USA
    Circ Cardiovasc Interv 3:308-16. 2010
    ..We sought to identify the clinical and angiographic predictors of cardiac ischemic events in patients with ACSs treated with an early invasive strategy...
  58. doi request reprint 5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial
    Gregg W Stone
    Department of Medicine, Division of Cardiology, Columbia University, Medical Center New York Presbyterian Hospital, Cardiovascular Research Foundation, New York 10022, USA
    JACC Cardiovasc Interv 4:300-9. 2011
    ..We sought to evaluate the utility of the JOSTENT polytetrafluoroethylene (PTFE) stent-graft (Jomed GmbH, Rangendingen, Germany) in patients with diseased saphenous vein grafts (SVGs) undergoing percutaneous coronary intervention (PCI)...
  59. ncbi request reprint Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study
    Kenichi Fujii
    Cardiovascular Research Foundation, Columbia University Medical Center, 55 East 59th Street, New York, NY 10022, USA
    J Am Coll Cardiol 45:995-8. 2005
    ..We sought to determine the predictors of stent thrombosis after sirolimus-eluting stent (SES) implantation...
  60. doi request reprint Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trial
    Philippe Genereux
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
    EuroIntervention 7:905-16. 2011
    ..There is a paucity of data comparing the TR approach with the TF approach in patients with STEMI treated with primary PCI and contemporary anticoagulant regimens...
  61. doi request reprint Intravascular ultrasound assessment of the incidence and predictors of edge dissections after drug-eluting stent implantation
    Xuebo Liu
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    JACC Cardiovasc Interv 2:997-1004. 2009
    ..We used intravascular ultrasound (IVUS) to assess incidence, predictors, morphology, and angiographic findings of edge dissections after drug-eluting stent (DES) implantation...
  62. doi request reprint Impact of mild or moderate renal insufficiency on the intravascular ultrasonic analysis of chronic vascular response to paclitaxel-eluting and bare-metal stents (from the TAXUS IV, V, and VI trials)
    Jiro Aoki
    Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 102:1009-16. 2008
    ..In conclusion, neointimal proliferation was less prominent and expansive vessel remodeling was more prominent after PES than BMS implantation, independent of the severity of renal dysfunction...
  63. doi request reprint Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial
    Jiro Aoki
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY, USA
    Circulation 119:687-98. 2009
    ..The clinical and angiographic predictors of early (<30 days) stent thrombosis (ST) have not been reported in high-risk patients with acute coronary syndromes...
  64. doi request reprint Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery L
    Gregg W Stone
    Columbia University Medical Center, Cardiovascular Research Foundation, 111 E 59th St, 11th Floor, New York, NY 10022, USA
    Circulation 119:680-6. 2009
    ..The safety and efficacy of EES after 1 year have not been reported...
  65. doi request reprint Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis
    Young Hak Kim
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 101:801-6. 2008
    ..However, bifurcation stenosis remains a significant predictor of unfavorable clinical outcome...
  66. doi request reprint Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trials
    Jiro Aoki
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York 10022, USA
    JACC Cardiovasc Interv 1:161-7. 2008
    ....
  67. ncbi request reprint Comparison of clinical outcomes using stents versus no stents after percutaneous coronary intervention for proximal left anterior descending versus proximal right and left circumflex coronary arteries
    Dale T Ashby
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascualr Institute, New York, New York 10022, USA
    Am J Cardiol 89:1162-6. 2002
    ..A stenting strategy for proximal LAD stenoses appears to attenuate the differences of clinical restenosis noted after non-stent PCI...
  68. doi request reprint Gender-based evaluation of the XIENCE V everolimus-eluting coronary stent system: clinical and angiographic results from the SPIRIT III randomized trial
    Alexandra J Lansky
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
    Catheter Cardiovasc Interv 74:719-27. 2009
    ..We evaluated the role of gender on clinical and angiographic results of the everolimus-eluting stent in the SPIRIT III trial...
  69. ncbi request reprint Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosis
    Kazuyuki Shirai
    Cardiovascular Research Foundation, Lenox Hill Hospital, New York, New York 10022, USA
    Am J Cardiol 92:1409-13. 2003
    ..In matched lesions, beta and gamma VBT achieved similar reductions in treated segment restenosis and recurrent lesion length compared with placebo...
  70. doi request reprint Impact of intravascular ultrasound imaging on early and late clinical outcomes following percutaneous coronary intervention with drug-eluting stents
    Bimmer E Claessen
    Cardiovascular Research Foundation, Clinical Trial Center, New York, New York, USA
    JACC Cardiovasc Interv 4:974-81. 2011
    ..This study sought to assess the impact of intravascular ultrasound (IVUS)-guided versus angiography-guided drug-eluting stent (DES) implantation...
  71. doi request reprint Prognostic significance of coronary thrombus in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial
    Kenji Goto
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    JACC Cardiovasc Interv 4:769-77. 2011
    ....
  72. ncbi request reprint Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    J Am Coll Cardiol 42:1900-5. 2003
    ..We sought to determine the impact of aggressive stent expansion on creatine kinase-MB isoenzyme (CK-MB) release and clinical restenosis...
  73. ncbi request reprint Effect of percutaneous coronary interventions for in-stent restenosis in degenerated saphenous vein grafts without distal embolic protection
    Dale T Ashby
    Lenox Hill Heart and Vascular Institute, New York, New York, USA
    J Am Coll Cardiol 41:749-52. 2003
    ..This study was designed to investigate the impact of percutaneous coronary interventions (PCIs) in degenerated saphenous vein grafts (SVGs) without distal embolic protection...
  74. ncbi request reprint Bivalirudin for patients with acute coronary syndromes
    Gregg W Stone
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
    N Engl J Med 355:2203-16. 2006
    ..We evaluated the role of thrombin-specific anticoagulation with bivalirudin in such patients...
  75. ncbi request reprint Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival: results from the Do Tirofiban and ReoProGive Similar Efficacy Outcome Trial (TARGET)
    Albert W Chan
    Department of Cardiology, Ochsner Clinic Foundation, New Orleans, Louisiana, USA
    J Am Coll Cardiol 42:1188-95. 2003
    ..We sought to examine if clopidogrel treatment initiated before coronary stenting improved clinical outcomes among patients receiving aspirin and a glycoprotein (GP) IIb/IIIa inhibitor...
  76. ncbi request reprint Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents
    Gregg W Stone
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
    N Engl J Med 356:998-1008. 2007
    ..Such studies have been inconclusive because of their insufficient size, the use of historical controls, a limited duration of follow-up, and a lack of access to original source data...
  77. ncbi request reprint Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial)
    Eugenia Nikolsky
    Cardiovascular Research Foundation, New York, New York 10022, USA
    Am J Cardiol 95:709-15. 2005
    ..Paclitaxel-eluting stents attenuate the increased risk associated with obesity, such that the intermediate-term prognosis after percutaneous coronary intervention is independent of weight...
  78. doi request reprint Impact of gender and age on in vivo virtual histology-intravascular ultrasound imaging plaque characterization (from the global Virtual Histology Intravascular Ultrasound [VH-IVUS] registry)
    Jie Qian
    Cardiovascular Research Foundation and Columbia University Medical Center, New York, New York, USA
    Am J Cardiol 103:1210-4. 2009
    ....
  79. ncbi request reprint Impact of in-hospital acquired thrombocytopenia in patients undergoing primary angioplasty for acute myocardial infarction
    Eugenia Nikolsky
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 96:474-81. 2005
    ..0% vs 3.9%, p = 0.03) in patients who developed thrombocytopenia. In conclusion, thrombocytopenia that develops after primary PCI for AMI, although uncommon, is associated with increased hemorrhagic complications and decreased survival...
  80. ncbi request reprint Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease
    Alexandra J Lansky
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    J Am Coll Cardiol 45:1180-5. 2005
    ..We sought to determine whether gender influences the results of paclitaxel-eluting stent implantation...
  81. ncbi request reprint Update on drug-eluting coronary stents
    Nicholas N Kipshidze
    Department of Interventional Cardiac and Vascular Services, Lenox Hill Hospital, New York, NY 10021, USA
    Expert Rev Cardiovasc Ther 3:953-68. 2005
    ..Recent advances in vascular gene transfer have also demonstrated potential new treatment modalities for cardiovascular disease, particularly in the treatment of vascular restenosis...
  82. ncbi request reprint Non-ST-elevation acute coronary syndromes
    Gregg W Stone
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 1022, USA
    Lancet 369:801-3. 2007
  83. ncbi request reprint Relation between the degree of procedural anticoagulation and complications after coronary stent implantation
    Dale T Ashby
    Cardiovascular Research Foundation and Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 92:319-22. 2003
    ..High levels of procedural anticoagulation with heparin were found to increase hemorrhagic complications without improving clinical or angiographic outcomes...
  84. doi request reprint Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudy
    Kenji Goto
    Cardiovascular Research Foundation, 111 E 59th St, 11th Floor, New York, NY 10022, USA
    Circulation 121:853-62. 2010
    ..We sought to assess the predictors of adverse cardiac events in patients with acute coronary syndrome assigned to medical management...
  85. doi request reprint Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial
    Frederick Feit
    Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York, USA
    J Am Coll Cardiol 51:1645-52. 2008
    ..We sought to evaluate clinical outcomes of patients with diabetes mellitus in the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial, overall and by treatment arm...
  86. doi request reprint Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial
    Gregg W Stone
    Columbia University Medical Center, The Cardiovascular Research Foundation, 111 E 59th St, 11th Floor, New York, NY 10022, USA
    JAMA 299:1903-13. 2008
    ....
  87. ncbi request reprint Successful use of the frontrunner catheter in the treatment of in-stent coronary chronic total occlusions
    Yi ming Yang
    Columbia University Medical Center and Cardiovascular Research Foundation, 161 Fort Washington Avenue, New York, NY 10032, USA
    Catheter Cardiovasc Interv 63:462-8. 2004
    ..TIMI 3 flow was achieved in all target vessels after further balloon angioplasty or stenting. The Frontrunner device is a safe and effective tool in the treatment of CTOs from ISR...
  88. ncbi request reprint Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial
    Gregg W Stone
    Department of Cardiology, Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY 10032, USA
    JAMA 294:1215-23. 2005
    ..Compared with bare metal stents, drug-eluting stents reduce restenosis in noncomplex lesions. The utility of drug-eluting stents has not been evaluated in more difficult stenoses...
  89. ncbi request reprint The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary intervention
    Adam J Saltzman
    Cardiovascular Medicine and the Center for Interventional Vascular Therapy, Columbia University Medical Center, 161 Fort Washington Avenue, New York, NY, 10032, USA
    J Invasive Cardiol 22:2-6. 2010
    ..We sought to compare the efficacy of tirofiban and abciximab on platelet inhibition as well as their effects of platelet inhibition on C-reactive protein levels during percutaneous coronary intervention (PCI)...
  90. doi request reprint Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease
    Gregg W Stone
    Columbia University Medical Center New York Presbyterian Hospital and the Cardiovascular Research Foundation, New York, NY 10022, USA
    N Engl J Med 362:1663-74. 2010
    ..Previous studies have established the superiority of coronary everolimus-eluting stents over paclitaxel-eluting stents with respect to angiographic findings. However, these trials were not powered for superiority in clinical end points...
  91. doi request reprint Effect of prolonged thienopyridine use after drug-eluting stent implantation (from the TAXUS landmark trials data)
    Gregg W Stone
    The Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 102:1017-22. 2008
    ....
  92. ncbi request reprint Impact and determinants of left ventricular function in patients undergoing primary percutaneous coronary intervention in acute myocardial infarction
    Amir Halkin
    Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 96:325-31. 2005
    ..Simple clinical and angiographic features readily available at the time of primary angioplasty also predict convalescent LVEF and are thus of prognostic utility...
  93. ncbi request reprint Gender differences in clinical outcome after coronary artery stenting with use of glycoprotein IIb/IIIa inhibitors
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 89:976-9. 2002
  94. ncbi request reprint Clinical outcomes after heterogeneous overlap stenting with drug-eluting stents and bare-metal stents for de novo coronary artery narrowings
    Jiro Aoki
    Center for Interventional Vascular Therapy, Columbia University Medical Center, New York, NY, USA
    Am J Cardiol 101:58-62. 2008
    ..In conclusion, the incidence of DES and BMS overlap stenting is rare in daily practice, but this procedure is associated with a high rate of target vessel revascularization...
  95. ncbi request reprint New-device angioplasty in women: clinical outcome and predictors in a 7,372-patient registry
    Alexandra J Lansky
    Cardiac Catheterization Laboratory and the Women s Cardiac Health Initiative, Lenox Hill Hospital, New York City, NY 10022, USA
    Epidemiology 13:S46-51. 2002
    ..To gain insight into the outcome of women after new-device angioplasty, we reviewed the early and late clinical outcome of 7,372 patients undergoing new-device angioplasty between 1991 and 1996 at the Washington Hospital Center...
  96. ncbi request reprint Optimal final lumen area and predictors of target lesion revascularization after stent implantation in small coronary arteries
    Ioannis Iakovou
    Cardiovascular Research Foundation, Lenox Hill Heart and Vascular Institute, New York, New York 10022, USA
    Am J Cardiol 92:1171-6. 2003
    ..Therefore, there does not appear to be any "downside" to aggressive stent implantation strategies in small vessels. In contrast, IVUS allows maximization of final lumen dimensions to minimize clinical restenosis...
  97. doi request reprint Meta-analysis of the effects of paclitaxel-eluting stents versus bare metal stents on volumetric intravascular ultrasound in patients with versus without diabetes mellitus
    Masashi Kimura
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York, USA
    Am J Cardiol 101:1263-8. 2008
    ....
  98. ncbi request reprint Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery
    George Dangas
    Columbia University Medical Center and Cardiovascular Research Foundation, New York, New York, USA
    J Am Coll Cardiol 45:1186-92. 2005
    ..We sought to examine the efficacy of paclitaxel-eluting stent implantation in the left anterior descending coronary artery (LAD)...
  99. ncbi request reprint Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score
    Amir Halkin
    Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
    J Am Coll Cardiol 45:1397-405. 2005
    ..We sought to develop a simple risk score for predicting mortality after primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI)...
  100. doi request reprint Necrotic core and its ratio to dense calcium are predictors of high-risk non-ST-elevation acute coronary syndrome
    Eduardo Missel
    Cardiovascular Research Foundation, Columbia University Medical Center, New York, NY, USA
    Am J Cardiol 101:573-8. 2008
    ..01) than patients with no predictors. In conclusion, VH-IVUS analysis showed that the percentage of NC and its ratio to DC in diseased coronary segments are positively associated with a high-risk ACS presentation...
  101. ncbi request reprint Correlation of coronary arterial remodeling determined by intravascular ultrasound with angiographic diameter reduction of 20% to 60%
    Makoto Hirose
    Cardiovascular Research Foundation, New York, NY 10021, USA
    Am J Cardiol 92:141-5. 2003
    ..7) were similar. Negative remodeling is frequently observed in lesions with intermediate stenosis. This suggests that negative remodeling occurs early in lesion formation...